We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$1.02B
AUM Growth
+$269M
Cap. Flow
+$29.8M
Cap. Flow %
2.93%
Top 10 Hldgs %
44.41%
Holding
92
New
31
Increased
16
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$36.6M
2
BABA icon
Alibaba
BABA
+$25.9M
3
ZBRA icon
Zebra Technologies
ZBRA
+$24.4M
4
ARMK icon
Aramark
ARMK
+$21.1M
5
COTY icon
Coty
COTY
+$20.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$24M
2
SGI
Somnigroup International
SGI
+$20.4M
3
KEYS icon
Keysight
KEYS
+$20.2M
4
RCL icon
Royal Caribbean
RCL
+$17.4M
5
RH icon
RH
RH
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Miscellaneous 24.67%
3 Industrials 11.95%
4 Technology 10.39%
5 Consumer Discretionary 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
26
Regeneron Pharmaceuticals
REGN
$81.8B
$12.8M 1.26%
+40,871
New +$13.6M
NOMD icon
27
Nomad Foods
NOMD
$1.66B
$12.7M 1.25%
595,199
+42,882
+8% +$899K
WSC icon
28
WillScot Mobile Mini Holdings
WSC
$3.79B
$12.1M 1.19%
806,476
FLXN
29
DELISTED
Flexion Therapeutics, Inc.
FLXN
$11.4M 1.12%
928,924
+44,906
+5% +$518K
ATNX
30
DELISTED
Athenex, Inc. Common Stock
ATNX
$11.2M 1.11%
28,397
+1,482
+6% +$411K
ZBH icon
31
Zimmer Biomet
ZBH
$19.2B
$11M 1.08%
96,543
+28,795
+43% +$3.37M
ARQL
32
DELISTED
Arqule Inc
ARQL
$10.9M 1.07%
+985,917
New +$6.86M
SAFM
33
DELISTED
Sanderson Farms Inc
SAFM
$10.5M 1.04%
+77,238
New +$11M
EDU icon
34
New Oriental
EDU
$9.36B
$9.84M 0.97%
+101,903
New +$9.12M
RCL icon
35
Royal Caribbean
RCL
$74.7B
$9.8M 0.96%
80,861
-142,532
-64% -$17.4M
CNC icon
36
Centene
CNC
$32B
$9.78M 0.96%
+186,583
New +$10.1M
LSCC icon
37
Lattice Semiconductor
LSCC
$16.2B
$9.75M 0.96%
668,468
CARM
38
DELISTED
Carisma Therapeutics
CARM
$9.25M 0.91%
308,309
+46,331
+18% +$1.39M
RPD icon
39
Rapid7
RPD
$896M
$8.72M 0.86%
150,825
+50,825
+51% +$2.67M
DIS icon
40
CALL
Walt Disney
DIS
$187B
$8.38M 0.82%
+60,000
New +$7.96M
AGN
41
DELISTED
Allergan plc
AGN
$8.37M 0.82%
+50,000
New +$6.92M
GTYH
42
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$8.22M 0.81%
+1,200,000
New +$10.5M
AAL icon
43
American Airlines Group
AAL
$9.03B
$7.78M 0.76%
+238,428
New +$7.7M
MRVL icon
44
Marvell Technology
MRVL
$195B
$7.36M 0.72%
308,200
-314,779
-51% -$7.35M
CRM icon
45
Salesforce
CRM
$211B
$7.23M 0.71%
47,646
-29,848
-39% -$4.68M
LGF.A
46
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$6.76M 0.66%
551,836
-449,591
-45% -$6.46M
DCPH
47
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6.68M 0.66%
296,346
+111,352
+60% +$2.61M
ATHM icon
48
PUT
Autohome
ATHM
$2.63B
$6.37M 0.63%
+74,400
New +$7.41M
OSW icon
49
OneSpaWorld
OSW
$2.56B
$6.21M 0.61%
400,750
+296,994
+286% +$4.09M
PTCT icon
50
PTC Therapeutics
PTCT
$5.85B
$6.17M 0.61%
+137,219
New +$5.42M

Similar funds

Kingdon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kingdon Capital Management held 92 positions worth $1.02B, up 36% from $748M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kingdon Capital Management's Q2 2019 filing shows 31 new, 16 increased, 12 reduced and 24 closed positions. Its largest new stake was Freeport-McMoran: 3,140,882 shares worth $36.5M. The largest sale was Celgene Corp, an estimated $24M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Miscellaneous and Industrials.

  • Kingdon Capital Management's largest Q2 2019 buy was Freeport-McMoran: 3,140,882 shares worth $36.5M.
  • Kingdon Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019, an estimated $8.86M increase.
  • Kingdon Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $17.4M.
  • Kingdon Capital Management fully exited Celgene Corp in Q2 2019, selling an estimated $24M.
  • Kingdon Capital Management's ten largest holdings make up 44% of its $1.02B portfolio in Q2 2019.
  • Kingdon Capital Management opened 31 new positions and closed 24 in Q2 2019.
  • Kingdon Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.